welcome
Ars Technica

Ars Technica

Health

Health

Norovirus vaccine hints at defusing explosive stomach bug in early trial

Ars Technica
Summary
Nutrition label

76% Informative

An experimental norovirus vaccine given as a pill produced defensive responses in the saliva of older people.

Norovirus causes an average of between 19 and 21 million cases of acute gastroenteritis in the U.S. every year .

90 percent of people who die from a norov virus infection are people age 65 or older who live in long-term care.

VR Score

79

Informative language

82

Neutral language

16

Article tone

informal

Language

English

Language complexity

56

Offensive language

offensive

Hate speech

likely hateful

Attention-grabbing headline

not detected

Known propaganda techniques

not detected

Time-value

long-living

Affiliate links

no affiliate links